Neuro Flashcards
1
Q
Bromocriptine
A
Parkinson
- **Dopamine agonist **
2
Q
Pramipexole
A
Parkinson
- **Dopamine agonist **
- ergot
3
Q
Ropinirole
A
Parkinson
- Dopamine agonist
- non ergot
4
Q
Amantadine
A
Parkinson
- **Increase dopamine release **
- Toxicity
- ataxia
- Also used as antiviral against influenza A and rubella
5
Q
L- Dopa
+
Carbidopa
A
Parkinson
- Increase dopamine
- L-dopa: converted to dopamine in CNS
- can cross BBB
- converted by dopa decarboxylase in CNS to dopamine
- Carbidopa: peripheral dopa decarboxylase inhibitor
- increases bioavailabilty of L-dopa in brain
- limits peripheral side effects
- no effect on CNS isde effect
- Toxicity
- arrhythmia- increased peripheral formation of catecholamines
- dyskinesia (following administration)
- akinesia (between doses)
- CNS
- anxiety, agitation, insomnia, confusion, delusions, hallucinations
- Do not give with vit B6
- increase coversion of l-dopa to dopamine in periphery
6
Q
Selegiline
A
Parkinson
- **Selective MAO- B inhibitor **
- preferentially metabolizes dopamine
- increasing availability of dopamine
- Clinical use
- adjuctive agent to L-dopa
- Toxicity
- may enhance adverse effects of L-dopa
7
Q
Entacapone
A
Parkinson
-
COMT inhibitor
- prevent L-dopa degradation
- increase dopamine availability
8
Q
Tolcapone
A
Parkinson
-
COMT inhibitors
- prevent L-dopa degradation
- increase levaopa availability
- hepatotoxicity
9
Q
Benztropine
A
Parkinson
- **Antimuscarinic **
- improves tremor, rigidity
- little effect on bradykinesia
- Use with drug induced parkinsonism from first generation antipsychotic
10
Q
Memantine
A
Alzheimer’s Disease
-
NMDA receptor antagonist
- prevent excitotoxicity
- mediated by Ca++
- Toxicity
- Dizziness
- Confusion
- Hallucinations
11
Q
Donepezil
A
Alzheimer’s
- **AChE Inhibitors **
- Toxicity
- nausea
- dizziness
- insomnia
12
Q
Galantamine
A
Alzheimer’s
- AChE inhibitors
- Toxicity
- nausea
- dizziness
- insomnia
13
Q
Rivastigmine
A
Alzheimer’s
- AChE inhibitors
- Toxicity
- nausea
- dizziness
- insomnia
14
Q
Tetrabenazine
A
Huntington’s
- Inhibit VMAT
- limit dopamine vesicle packaging and release
15
Q
Reserpine
A
Huntington
-
Inhibit VMAT
- limit dopamine vesicle packaging and release
16
Q
Haloperidol
A
Huntington
- **dopamine receptor antagonist **
17
Q
Sumatriptan
A
Migraine + Cluster Headaches
-
5-HT agonist
- inhibits trigeminal nerve activation
- prevents vasosctive peptide release (substance P + CGPR)
- induces vasoconstriction
- half life 2 hours
- Toxicity
- coronary vasospasm
- dont use in CAD or prinzmetal’s angina
- mild tingling
- coronary vasospasm
18
Q
Succinylcholine
A
Neuromuscular Blocking Drugs
- Muscle paralysis in surgery or mechanical ventilation
- Selective for motor nicotinic receptor
- Depolarizing
- Binds ACh receptor keeping it depolarized
- prevents muscle contraction
- Reversal of blockage
- phase 1: no antidote, block potentiated by cholinesteraes inhibitors
- phase 2: antidote = cholinesteraes inhibitors
- neostigmine
- Complications
- hypercalcemia
- hyperkalemia
- can lead to arrhythmias in peopel predisposed to hyperkalemia (burns, myopathies, crush injury, denervating injuries or disease)
- *malignant hyperthermia *
19
Q
Tubocurarine
Atracurium
Mivacurium
Pancuronium
Vecuronium
Rocuronium
A
Neuromusclar blocking drugs
- Muscle paralysis in surgery or mechanical ventilation
- selective for motor and nicotinic receptor
- Nondepolarizing
- Competitive ACh receptor antagonist
- Reversalof blockage
- neostigmine
- edrophonium
- cholinesterase inhibitors
20
Q
Dantrolene
A
Malignant Hyperthermia
- **Prevent Ca++ release from sarcoplasmic reticulum of skeletal muscle **
- Malignant Hyperthermia
- life threatening
- inherited susceptibility
- Neuroleptic malignany syndrome
- toxicity of antipsychotic drugs
21
Q
Procaine
Cocaine
Tetracaine
A
Local anesthetic
- Ester = “caine”
- Mechanism
-
block activated Na+ channels
- specifically inhibit rapidly firing neurons
-
block activated Na+ channels
- Principle
- give with vasoconstrictors (epi) to enhance local action
- decrease bleeding
- increase anesthesia
- decrease systemic concentration
- Infected tissue (acidic)
- need more anesthetic
- alkaline are charged adn can’t penetrate membrane
- need more anesthetic
- give with vasoconstrictors (epi) to enhance local action
- Clinical use
- minor surgical procedures
- spinal anesthesia
- toxicity
- CNS excitation
- HTN
- Hypotension
- Arrhythmias = cocaine
22
Q
Local anesthetic
nerve blockade order
A
- Small diameter > large diameter
- Myelinated > unmyelinated
- Size > Myelination
- Small myelinated > small unmyelinated > large myelinated > large unmyelinated
- Order of loss
- pain > temp > touch > pressure
23
Q
Lidocaine
A
Local anesthetic
- Amide = two i
- Mechanism
-
block activated Na+ channels
- penetrate membrane in uncharged form then bind channel in charged form
- most effective in rapidly firing neurons
-
block activated Na+ channels
- Principles
- give with vasoconstrictors (epi) to enhance local action
- decrease bleeding
- increase anesthesia
- decrease systemic concentration
- Infected tissue (acidic)
- need more anesthetic
- alkaline anesthetics cant penetrate membrane
- need more anesthetic
- give with vasoconstrictors (epi) to enhance local action
- Clinical use
- minor surgical procedures
- spinal anesthesia
- Toxicity
- CNS excitation
- HTN
- Hypotension
24
Q
Mepivacaine
A
Local anesthetic
- amide = 2 i
- Mechanism
-
block activated Na+ channels
- penetrate membrane in uncharged form and bind channel in charged form
- most effective in rapidly firing neurons
-
block activated Na+ channels
- Principle
- give with vasoconstrictors (epi) to enhance local action
- decrease bleeding
- increase anesthesia
- decrease systemic concentration
- infected tissue (Acidic)
- need more anesthetic
- alkaline anesthetics are charged so cant pennetrate membrane
- need more anesthetic
- give with vasoconstrictors (epi) to enhance local action
- Use
- minor surgical procedures
- spinal anesthetica
- Toxicity
- CNS excitation
- HTN
- Hypotension
25
Bupivacaine
local anesthetic
* Amide = 2 i
* Mechanism
* **Block active Na+ channels**
* penetrate membrane in uncharged form adn bind ion channel in charged form
* most effective in rapidly firing neurons
* Principle
* give with vasoconstrictors (epi) to enhance local action
* decrease bleeding
* increase anesthesia
* decrease systemic concentration
* infected tissue (Acidic)
* give more anesthetic
* alkaline anesthetics charged and can't penetrate membrane
* Use
* minor surgeries
* spinal anesthesia
* Toxicity
* CNS excitation
* **severe CV toxicity**
* HTN
* Hypotension
26
Thiopental
IV anesthetic
* **Barbituate**
* high potency, high lipid solubility
* rapid entry into brain
* Use
* Anesthesia induction
* short surgical procedures
* characteristics
* **rapid redistribution into tissue and fat**
* decreases cerebral flow
27
Midazolam
IV anesthetic
* **Benzodiazapine**
* Use
* endoscopy
* use with gaseous anesthetics and narcotics
* Toxicity
* severe postop respiratory depression
* decrease BP
* give flumazenil
* amnesia
28
Ketamine
IV anesthetic
* Aka: arylcyclohexamines
* PCP analog
* **Block NMDA receptor **
* *CV stimulant*
* *increase cerebral blood flow *
* Toxicity
* disorientation
* hallucinations
* bad dreams
29
Morphine
IV anesthetics
* **opioid**
* Use
* general anesthesia
* use with other CNS depressants
30
Fentanyl
IV anesthetics
* Opioid
* Use
* general anesthesia
* use with other CNS depressants
31
Proprofol
IV anesthetic
* Potentiation GABA
* Less postop nausea than thiopental
* Use
* sedation in ICU
* rapid anesthesia induction
* short procedures
32
Modafinil
Narcolepsy
* Pyschostimulant
* non amphetamine
* first line
* effective
* well tolerated
* drug abuse is rare
33
Pentazocine
Class
MOA
Use
Toxicity
* opioid analgesic
* MOA: Partial agonist adn weak antagonist at mu receptors
* Use:
* effective analgesia with little abuse potential
* Toxicity
* Used in combo with full opioid agonists --\> competitively inhibit mu receptors and produce antagonist effects reducing analgesic effect
* Patient dependent on opioid (morphine) --\> withdrawal symptoms
34
Cyproheptadine
- MOA
- Use
* MOA
* 1st generation histamine antagonist
* nonspecific 5-HT1 and 5-HT2 receptor antagonist properties
* Use
* Serotonin syndrome
* Serotonin Syndrome
* neuromuscular excitation
* hyperreflexia
* clonus
* myoclonus
* rigidity
* flushing
* diarrhea
* seizures
* autonomic stimulation
* hyperthermia
* tachycardia
* CV collapse
* diaphoresis
* tremor
* altered mental status
* agitation
* confusion
35
Phentyoin
* seizure
* simple
* complex
* tonic clonic- first line
* status epilepticus- first line
* moa
* increase Na+ channel inactivation
* toxicity
* nystagmus
* diplopia
* ataxia
* sedation
* gingival hyperplasia
* hirsutism
* megoblastic anemia
* teratogen
* fetal hydantoin syndrome
* SLE like syndrome
* CYP induce
* lymphadenopathy
* steven johnson syndrome
36
Carbamazepine
* seizures
* simple- 1st line
* complex- 1st line
* tonic clonic- 1st line
* trigeminal neuralgia
* Bipolar - mood stabilizer
* moa
* increase Na+ channel ianctivation
* toxicity
* diplopia
* ataxia
* blood dyscarasias
* agranulocytosis
* aplastic anemia
* liver toxicity
* teratogen
* Cyp inducer
* SIADH
* Steven johnson
37
Lamotrigine
* seizures
* simple
* complex
* tonic-clonic
* moa
* blocks voltage gated Na+ channels
* toxicity
* steven johnson syndrome
38
Gabapentin
* seizures
* simple
* ecomplex
* tonic clonic
* peripheral neuropathy
* postherpetic neuralgia
* migraine prophylaxis
* bipolar
* moa
* inhibit high voltage activated Ca++ channels
* GABA analog
* toxicity
* sedation
* atazia
39
Topiramate
* seizures
* simple
* complex
* tonic clonic
* migraine prevention
* moa
* block Na+ channels
* increase GABA action
* toxicity
* sedation
* mental dulling
* kidney stones
* weight loss
40
Phenobarbital
* seizures
* simple
* complex
* tonic-clonic
* 1st line kids
* moa
* increase GABA action
* increase **duration** fo Cl- openning
* toxicity
* Respirator and CV depression
* can be fatal
* Sedation
* CNS depression exacerbated by alcohol
* tolerance
* dependence
* CYP inducer
41
Valproic acid
* seizues
* simple
* complex
* tonic clonic- first line
* absence
* myoclonic seizures
* Bipolar --\> mood stabilizer
* use if poor kidneys b/c can't give lithum (renal excretion)
* moa
* increase Na+ channel inactivation
* increase GABA concentration
* toxicity
* GI distress
* rare but fatal hepatotoxicity (measure LFT)
* teratogen- neural tube defects
* spina bifida
* tremor
* weight gain
42
ethosuximide
* seizures
* absence- 1st line
* moa
* block thalamic t type Ca+ channels
* toxicity
* GI distres
* fatigue
* headache
* urticaria
* steven johnson syndrome
43
Benzodiazepines
diazepam
lorazepam
* seizures
* status epilepticus - 1st line
* moa
* increase GABA actio
* increase **frequency** of Cl- channel openning
* toxicity
* sedation
* do not give with alcohol, barbituatesm, neuroleptics, 1st generation antihistamines
* tolerance
* dependence
44
Tiagabine
* seizures
* simple
* complex
* moa
* inhibit GABA reputake
45
Vigabatrin
* seizures
* simple
* complex
* moa
* irreversible inhibit GABA transaminase
* increase GABA
46
Levetiracetam
* seizures
* simple
* complex
* tonic-clonic
* mechanism
* unknown
47
Primidone
* seizures
* essential tremors
* moa
* metabolized into phenobarbital + phenylethylmalonamide (PEMA)